Incyte Corp is a biopharmaceutical company focused on developing and commercializing treatments for cancer and autoimmune diseases. It is known for its flagship product, JAKAFI, used in treating various blood-related disorders, and has a diverse portfolio including therapies for leukemia, lymphoma, and skin diseases. Incyte is actively involved in research, with several products in clinical trials aiming to address unmet medical needs in oncology and inflammation. The company collaborates with other pharmaceutical entities to expand its reach and improve patient care globally. Headquartered in Wilmington, Delaware, Incyte continues to innovate in the healthcare space.
Wall Street is firing on all cylinders this Thursday, with major upgrades hitting healthcare, telecom, and e-commerce while Treasury bond buybacks shake up yields and send gold surging past $4,500. Find out…
Pre-Market Stock Futures: Futures are trading mixed as we prepare to finish the last full week of the second quarter. We finished a wild holiday-shortened trading week last Thursday, as Friday was…
Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and seek exposure to next-generation therapeutic platforms. Five biotechs stand out as compelling acquisition candidates, each…
Pre-Market Stock Futures: The futures are trading higher as we start the new trading week. There is an old saying, “Fool me once, shame on you; fool me twice, shame on me.”…
Pre-Market Stock Futures: Futures are trading lower once again after another up-and-down day on Wall Street. Once again, the rotation narrative rang out as software and chip stocks were hit hard, and…
Friday's top analyst upgrades and downgrades included Builders FirstSource, CVS Health, DHT, Incyte, McDonald's, Newell Brands, PacWest Bancorp, Wingstop and ZoomInfo Technologies.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Amcor, Caesars Entertainment, CarMax, Chewy, Marriott International, Microsoft, Molson Coors Beverage, NXP Semiconductors and Uber Technologies.
Tuesday's top analyst upgrades and downgrades included American Homes 4 Rent, Block, Catalent, Cushman & Wakefield, Hasbro, McDonald's, NetApp, Pioneer Natural Resources, Regions Financial, Southwestern Energy, Tyson Foods, Warner Bros. Discovery and…
Tuesday's top analyst upgrades and downgrades included Alphabet, Caterpillar, Corning, Digital Realty Trust, Dish Network, KeyCorp, Nvidia, Pinterest, Roku, Tesla and Wynn Resorts.
Monday's top analyst upgrades and downgrades included Altria, Block, Coinbase Global, Deere, First Horizon, KB Home, Pfizer, PNC Financial Services, RingCentral, Uber Technologies znd Zoom Video Communications.
Tuesday's top analyst upgrades and downgrades included Amgen, Caterpillar, CF Industries, Coinbase Global, Fastly, Match, Newmont, Okta, Progressive, Toast, Under Armour, Walt Disney and Zim Integrated Shipping Services.
More AI-enabled search chatbots to compete with Google, and Manchester United may have found a buyer.
Wednesday's top analyst upgrades and downgrades included Alphabet, Bank of America, Dollar General, Edwards Lifesciences, Fortinet, Fox, Halliburton, LyondellBasell Industries, Paramount Global, SoFi Technologies and Truist Financial.
Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive, Snowflake, SoFi Technologies, XPO Logistics and Zoominfo Technologies.
Wednesday's top analyst upgrades and downgrades included Coterra Energy, EOG Resources, FedEx, Fortinet, Hertz Global, Palo Alto Networks, Range Resources, Stem, TechnipFMC, Twilio and United Parcel Service.
